Novartis (NVS) Receives Positive CHMP Opinion for Updated Arzerra Marketing Terms
Go back to Novartis (NVS) Receives Positive CHMP Opinion for Updated Arzerra Marketing Terms| NOVARTIS AG (NYSE: NVS) | Delayed: 94.36 +1.79 (1.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.57 | 52 Week High | $89.15 | |||
| Open | $93.20 | 52 Week Low | $69.84 | |||
| Day High | $94.50 | P/E | N/A | |||
| Day Low | $93.15 | EPS | $0.00 | |||
| Volume | 2,338,264 | |||||
